Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6064769 | Journal of Allergy and Clinical Immunology | 2015 | 20 Pages |
Abstract
PGD2 and LTE4 activate TH2 cells through different pathways but act synergistically to promote multiple downstream effector functions, including neutrophil migration and survival. Combined inhibition of both PGD2 and LTE4 pathways might provide an effective therapeutic strategy for allergic responses, particularly those involving interaction between TH2 cells and neutrophils, such as in patients with severe asthma.
Keywords
qPCRRetinoic acid–related orphan receptor γtLTE4CysLT2CysLT1LTC4Cysteinyl leukotrieneCysLTLTD4CAIARORγtICAMphorbol 12-myristate 13-acetateCRTH2cysteinyl leukotriene receptor 2PGD2PI3KPMAQuantitative PCRTH2 cellsphosphoinositide 3-kinaseleukotriene E4chemoattractant receptor-homologous molecule expressed on Th2 cellsintercellular adhesion moleculeNeutrophilsProstaglandin D2cysteinyl leukotriene receptor 1
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Luzheng PhD, Joannah BSc, Maryam MD, Isabel BTA, James E. PhD, FRCPA, Ahmed N. MD, PhD, Shân L. PhD, David G. PhD, Michael G. PhD, Roy PhD, Graham DPhil, FRCP, Paul FMedSci,